Company Profile
Dr. Reddy's Laboratories Ltd Stock Price, News & Analysis
- Ticker:
- RDY
- Exchange:
- NYSE
- Sector:
- Biopharma
- Location:
- India and listed in the U
Stock performance
12.11 USD (-0.25%)
Close
Last updated: August 6, 2026
10.8B USD
Market cap
Why the stock is moving
As of Aug 6, 2026, RDY was little changed and closed at $12.11. No new same-company headline was identified in the current news window.
Company overview
Business overview
Dr. Reddy’s Laboratories is a global pharmaceutical company with a broad mix of generics, biosimilars, and specialty products. Its business is defined by scale, manufacturing, and a diversified international footprint.
Geographic Base and Sector Classification
Headquartered in India and listed in the U.S. as an ADR, Dr. Reddy’s has a large global presence across emerging and developed markets. It sits in generics and diversified pharmaceuticals rather than biotech.
Business Model Characteristics
The company generates value through product volume, manufacturing execution, and portfolio breadth across regulated and emerging markets. Investors watch pricing pressure, product launches, and margin discipline.
Position Within the Biotechnology Landscape
Dr. Reddy’s is not a biotech company, but it is relevant to the broader pharma landscape because it participates in biosimilars and global drug supply. Its stock is driven by manufacturing and commercial execution, not clinical catalysts.
Future catalysts
Dr. Reddy’s catalysts are US generics execution, biosimilar filings, and continued margin discipline. This matters because it helps show whether the company can turn its current footprint into a cleaner earnings profile. Better execution here can matter even before a new product or trial headline lands.
Recent news
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Dr. Reddy's Laboratories Ltd (RDY)?
Dr. Reddy's Laboratories Ltd (RDY) most recently closed at 12.11 USD, a -0.25% move versus the previous session.
What is the market cap of Dr. Reddy's Laboratories Ltd (RDY)?
Dr. Reddy's Laboratories Ltd currently has a market capitalization of 10.8B USD on BioPharmSignal.
What does Dr. Reddy's Laboratories Ltd do?
Dr. Reddy’s Laboratories is a global pharmaceutical company with a broad mix of generics, biosimilars, and specialty products. Its business is defined by scale, manufacturing, and a diversified international footprint.
On which exchange is RDY stock listed?
Dr. Reddy's Laboratories Ltd (RDY) is associated with NYSE, India and listed in the U, Biopharma.
What is Reddy?
Reddy’s catalysts are US generics execution, biosimilar filings, and continued margin discipline.
Which conditions is Dr. Reddy's Laboratories Ltd targeting with Reddy?
Reddy’s catalysts are US generics execution, biosimilar filings, and continued margin discipline.
How does Dr. Reddy's Laboratories Ltd describe recent progress with Reddy?
Reddy’s catalysts are US generics execution, biosimilar filings, and continued margin discipline.
What is Laboratories?
Reddy’s Laboratories is a global pharmaceutical company with a broad mix of generics, biosimilars, and specialty products.